ArticleJMIR mental health2019
Use of a Mobile Phone App to Treat Depression Comorbid With Hypertension or Diabetes: A Pilot Study in Brazil and Peru.
Article in JMIR mental health, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06658756 (Implementation of Internet-Based Psychotherapy for Obsessive-Compulsive Disorder), which is not on this map. Cited by 33 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Implementation of Internet-Based Psychotherapy for Obsessive-Compulsive Disorder (OCD) in Primary Health Care in Two Cities in the State of São Paulo
Who cites it
33 citing papers in PubMed, 2 syntheses or guidelines pooled it, 90 citations in OpenAlex.
- The effectiveness of mental health interventions involving non-specialists and digital technology in low-and middle-income countries - a systematic review.BMC public health · 2024Pooled it
- Feasibility of mHealth interventions for depressive symptoms in Latin America: a systematic review.International review of psychiatry (Abingdon, England) · 2021Pooled it
- Do baseline participant characteristics impact the effectiveness of a mobile health intervention for depressive symptoms? A post-hoc subgroup analysis of the CONEMO trials.Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) · 2024Trial
- Trial
- A scoping review of the characteristics, responsibilities, implementations and evaluations of digital navigators in healthcare.NPJ digital medicine · 2026Article
- PsyAPP: The Development of a Mobile Application for Effective Health Management in Mentally Ill Patients.Journal of clinical medicine · 2026Article
- Non-pharmacological and psychosocial interventions for comorbid hypertension and depression: a scoping review.BMJ open · 2025Article
- Risk prediction of cardiometabolic diseases with depression in the community of Xinjiang production and construction corps.BMC public health · 2025Article
- Home-based digital counselling by frontline community workers for anxiety and depression symptoms in rural Sindh, Pakistan: the mPareshan intervention.BMC public health · 2025Article
- Association between depression and medication adherence in noncommunicable diseases: a narrative review.Korean journal of family medicine · 2025Article
- Digital health interventions for non-communicable disease management in primary health care in low-and middle-income countries.NPJ digital medicine · 2023Review
- A CBT-based mobile intervention as an adjunct treatment for adolescents with symptoms of depression: a virtual randomized controlled feasibility trial.Frontiers in digital health · 2023Article
- Text Messages for Depression, Anxiety and Alcohol Abuse Therapy-Are Construction Guidelines Needed?International journal of environmental research and public health · 2022Article
- Digital Health Interventions for Depression and Anxiety Among People With Chronic Conditions: Scoping Review.Journal of medical Internet research · 2022Article
- Participants' and Nurses' Experiences With a Digital Intervention for Patients With Depressive Symptoms and Comorbid Hypertension or Diabetes in Peru: Qualitative Post-Randomized Controlled Trial Study.JMIR human factors · 2022Article
- The NEVERMIND e-health system in the treatment of depressive symptoms among patients with severe somatic conditions: A multicentre, pragmatic randomised controlled trial.EClinicalMedicine · 2022Article
- Human Support in App-Based Cognitive Behavioral Therapies for Emotional Disorders: Scoping Review.Journal of medical Internet research · 2022Article
- Implementation and scalability of a digital intervention to reduce depressive symptoms in people with diabetes, hypertension or both in Brazil and Peru: a qualitative study of health system's stakeholders' perspectives.Discover mental health · 2022Article
- Engagement with mobile health interventions for depression: A systematic review.Internet interventions · 2021Review
- Examining the Effectiveness of Gamification in Mental Health Apps for Depression: Systematic Review and Meta-analysis.JMIR mental health · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 5 institutions in 4 countries.
Funding
Abstract
backgroundDepression is underdiagnosed and undertreated in primary health care. When associated with chronic physical disorders, it worsens outcomes. There is a clear gap in the treatment of depression in low- and middle-income countries (LMICs), where specialists and funds are scarce. Interventions supported by mobile health (mHealth) technologies may help to reduce this gap. Mobile phones are widely used in LMICs, offering potentially feasible and affordable alternatives for the management of depression among individuals with chronic disorders.
objectiveThis study aimed to explore the potential effectiveness of an mHealth intervention to help people with depressive symptoms and comorbid hypertension or diabetes and explore the feasibility of conducting large randomized controlled trials (RCTs).
methodsEmotional Control (CONEMO) is a low-intensity psychoeducational 6-week intervention delivered via mobile phones and assisted by a nurse for reducing depressive symptoms among individuals with diabetes or hypertension. CONEMO was tested in 3 pilot studies, 1 in São Paulo, Brazil, and 2 in Lima, Peru. Depressive symptoms were assessed using the Patient Health Questionnaire-9 (PHQ-9) at enrollment and at 6-week follow-up.
resultsThe 3 pilot studies included a total of 66 people. Most participants were females aged between 41 and 60 years. There was a reduction in depressive symptoms as measured by PHQ-9 in all pilot studies. In total, 58% (38/66) of the participants reached treatment success rate (PHQ-9 <10), with 62% (13/21) from São Paulo, 62% (13/21) from the first Lima pilot, and 50% (12/24) from the second Lima pilot study. The intervention, the app, and the support offered by the nurse and nurse assistants were well received by participants in both settings.
conclusionsThe intervention was feasible in both settings. Clinical data suggested that CONEMO may help in decreasing participants' depressive symptoms. The findings also indicated that it was possible to conduct RCTs in these settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.